Bank of New York Mellon Corp - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 71 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$61,000
-26.5%
98,1150.0%0.00%
Q3 2019$83,000
+25.8%
98,1150.0%0.00%
Q2 2019$66,000
-80.1%
98,115
-75.8%
0.00%
Q1 2019$332,000
-51.0%
404,772
-4.5%
0.00%
Q4 2018$678,000
-38.1%
423,673
+28.0%
0.00%
Q3 2018$1,096,000
+68.4%
331,010
+14.9%
0.00%
Q2 2018$651,000
+195.9%
288,073
+279.0%
0.00%
Q1 2018$220,000
-14.1%
76,014
-17.0%
0.00%
Q4 2017$256,000
+7.1%
91,625
+40.2%
0.00%
Q3 2017$239,000
+45.7%
65,347
-11.7%
0.00%
Q2 2017$164,000
+221.6%
74,011
-13.8%
0.00%
Q1 2017$51,000
+54.5%
85,856
+40.4%
0.00%
Q4 2016$33,000
-43.1%
61,160
-6.5%
0.00%
Q3 2016$58,000
-22.7%
65,390
-15.6%
0.00%
Q2 2016$75,000
+5.6%
77,460
+0.9%
0.00%
Q1 2016$71,000
-26.8%
76,745
+0.0%
0.00%
Q4 2015$97,000
+4.3%
76,7440.0%0.00%
Q3 2015$93,000
-30.6%
76,744
-0.0%
0.00%
Q2 2015$134,000
+39.6%
76,747
+15.9%
0.00%
Q1 2015$96,000
+71.4%
66,2380.0%0.00%
Q4 2014$56,000
-23.3%
66,238
+0.1%
0.00%
Q3 2014$73,000
-69.8%
66,190
-50.0%
0.00%
Q2 2014$242,000
-30.5%
132,380
-43.2%
0.00%
Q1 2014$348,000
-19.6%
233,124
-1.5%
0.00%
Q4 2013$433,000
-55.1%
236,634
-49.4%
0.00%
Q3 2013$964,000
+63.4%
467,272
+97.8%
0.00%
Q2 2013$590,000236,1750.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
NEA Management Company, LLC 20,896,038$33,434,0001.33%
X-Square Capital, LLC 270,680$433,0000.34%
Granahan Investment Management 2,508,261$4,013,0000.28%
683 Capital Management, LLC 1,875,000$3,000,0000.18%
New Leaf Venture Partners, L.L.C. 402,118$643,0000.18%
Caption Management, LLC 855,000$1,366,0000.11%
Private Portfolio Partners LLC 51,000$82,0000.05%
Evercore Wealth Management, LLC 418,414$669,0000.02%
Fosun International Ltd 206,491$335,0000.02%
EXCALIBUR MANAGEMENT CORP 11,000$18,0000.02%
View complete list of AVEO PHARMACEUTICALS INC shareholders